VAERS reports by lot

GSK DTaP/Tdap lot Z9MZ2: VAERS reports

28 VAERS reports list lot Z9MZ2 as a GSK DTaP/Tdap vaccine, received between 2019-11-22 and 2022-04-21. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
28
Reports
0%
Marked serious
0
With a death outcome
18
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2166%
Allergic / Anaphylactic412%
Psychiatric / Neuropsychiatric39%
General / Systemic (non-local)26%
Cardiac / Cardiovascular13%
Dermatological (non-injection-site)13%

Where reports came from

U.S. state of the reporter, where given (top 12).

North Carolina4
Pennsylvania3
Ohio2
Oregon2
Michigan2
Colorado2
Kentucky2
Guam1
Louisiana1
Georgia1
California1
Florida1

Reports by month received

2019-111
2019-121
2020-022
2020-035
2020-061
2020-072
2020-091
2020-101
2021-041
2021-053
2021-061
2021-071
2021-082
2021-121
2022-011
2022-021
2022-032
2022-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.